Products Fezolinetant + Placebo
Fezolinetant + Placebo Phase 2 Completed ⚡ Active Jul 19, 2017 → Sep 19, 2018
About Fezolinetant + Placebo Fezolinetant + Placebo is a phase 2 stage product being developed by Astellas Pharma for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT03192176. Target conditions include Menopause, Hot Flashes.
Clinical Trials (12) NCT ID Phase Status Start Completion Indication NCT06917313 Phase 2 Recruiting Dec 5, 2025 Mar 1, 2028 Breast Cancer Early Stage Breast Cancer (Stage 1-3) NCT06812754 Phase 2 Completed Mar 10, 2025 Mar 5, 2026 Hot Flashes NCT06206421 Phase 3 Active Feb 22, 2024 Mar 31, 2026 Hot Flashes NCT06206408 Phase 3 Completed Feb 16, 2024 Dec 18, 2025 Hot Flashes NCT05034042 Phase 2 Completed Nov 17, 2021 Dec 23, 2022 Hot Flashes NCT05033886 Phase 3 Completed Nov 8, 2021 Apr 20, 2023 Vasomotor Symptoms NCT04234204 Phase 3 Completed Mar 17, 2020 Apr 20, 2022 Hot Flashes NCT04003155 Phase 3 Completed Jul 11, 2019 Aug 11, 2021 Hot Flashes NCT04003142 Phase 3 Completed Jul 10, 2019 Apr 23, 2021 Hot Flashes NCT04003389 Phase 3 Completed Jul 10, 2019 Jan 4, 2022 Hot Flashes NCT03192176 Phase 2 Completed Jul 19, 2017 Sep 19, 2018 Menopause NCT05419908 Phase 2 Completed Sep 21, 2015 Oct 6, 2016 Hot Flashes
Product Company Stage Hype Score atomoxetine + placebo Eli Lilly Pre-clinical Cetrorelix Shionogi Pre-clinical Teriparatide (PTH 1-34) Eli Lilly Phase 2/3 Eszopiclone + Placebo Sumitomo Pharma Pre-clinical Comparator: placebo + Comparator: Estrace Merck Phase 1 esmirtazapine + Placebo Merck Phase 3 Marketed low dose hormone replacement therapy Novo Nordisk Pre-clinical 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) Novo Nordisk Pre-clinical 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Approved estradiol, 10 mcg + estradiol, 25 mcg + placebo Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Pre-clinical estradiol, 10 mcg Novo Nordisk Phase 3 estradiol, 10 mcg + estradiol, 25 mcg Novo Nordisk Phase 1 estradiol, 10 mcg Novo Nordisk Phase 3 2 mg estradiol / 1 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Phase 3 estradiol, 25 mcg Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placebo Novo Nordisk Phase 3 estradiol, 25 mcg + estradiol, 25 mcg Novo Nordisk Phase 1
Other Products from Astellas Pharma